TB
D Timothy Bishop
Also known as: David Timothy Bishop
University of Leeds, Cancer Research UK, University of Sheffield, University of Bristol, University of Utah
Research areas: Medicine · Oncology · Genetic Associations and Epidemiology · Genetic factors in colorectal cancer · Cutaneous Melanoma Detection and Management
Employment
-
University of Leeds Director2012 - 2018
-
University of Leeds Professor2008 - Present
-
Cancer Research UK Principal Scientist1989 - 2008
-
University of Utah Associate Professor1984 - 1989
-
University of Utah Research Assistant Professor1977 - 1984
Education
- 1975 - 1977
-
University of Bristol M. Sc. Statistics1974 - 1975
-
University of Bristol B.Sc. Mathematics with Computer Science1971 - 1974
Projects & Funding
-
Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre Medical Research Council2014 - 2019
-
Genetic epidemiology of melanoma susceptibility and survival Cancer Research UK2014 - 2019
-
Large equipment bid for Leeds Centre: Request for an Agilent Bravo liquid handling platform, a Fluidigm BioMark genetic analysis system and an Arcturus laser capture microdissection system Cancer Research UK2010 - 2011
-
Biomarkers of prognosis and response to treatment for melanoma Cancer Research UK2009 - 2013
-
Biomarkers of prognosis and response to treatment for melanoma Cancer Research UK2009 - 2013
-
Genetic Epidemiology of Cancer Cancer Research UK2009 - 2015
-
Bishop - Research Services Cancer Research UK2009 - 2010
-
SP4006 - Staff Pool Award Cancer Research UK2006 - 2007
-
Pilot study for the development of a Familial Cancer Database in two centres (Part 2 of 2: Leeds element) Cancer Research UK2006 - 2008
-
The design and statistical analysis of whole genome association studies: application to melanoma Cancer Research UK2006 - 2010
-
Genetic Epidemiology of Cancer Cancer Research UK2004 - 2009
-
Colorectal Adenoma/carcinoma Prevention Project 2 (CAPP2): RCT of aspirin and resistant starch in HNPCC(Lynch Syndrome) Medical Research Council2002 - 2008
-
Genetic Epidemiology of Melanoma (GenoMel) National Cancer Institute2001 - 2018
-
LINKAGE ANALYSIS AND MULTIPLE LOCI National Cancer Institute1984 - 1986
Publications (822)
- Is Less More? An Update on Aspirin for Cancer Prevention in Lynch Syndrome From the Cancer Prevention Programme—CaPP Save
- Data from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 1 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 10 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 11 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 12 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 2 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 3 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 4 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 5 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 6 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 7 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 8 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Supplementary Table 9 from Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis Save
- Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes Save
- Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort Save
- Data from Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis Save
- Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis Save
- Table S1 from Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis Save